GlassScriptPhysician profile
Dana M Coberly
NPI 1356395891
$8,632.89
in general payments reported to CMS, 2019-2025
18 companies · $866 in 2025
The $866 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,296 · 2020: $433 · 2021: $563 · 2022: $1,066 · 2023: $1,895 · 2024: $515 · 2025: $866.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,276.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,275.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $3,868.89 | 2019-2022 | |
| Merz North America, INC. | $1,513.49 | 2019-2025 | Xeomin |
| Mentor Worldwide LLC | $789.37 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander |
| Tela Bio, INC. | $465.13 | 2021-2024 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Abbvie INC. | $406.97 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Botox |
| Integra Lifesciences Corporation | $267.31 | 2021-2025 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Baxter Healthcare | $251.41 | 2019-2025 | Tisseel |
| Davol INC. | $209.02 | 2022 | |
| Innovation Technologies INC | $176.13 | 2022 | |
| Motiva USA, LLC | $160.29 | 2025 | |
| Galderma Laboratories, L.P. | $150.00 | 2020 | |
| Smith+Nephew, INC. | $118.07 | 2019-2024 | Pico 14 |
| Tepha INC | $78.18 | 2020 | |
| Rti Surgical, INC | $66.21 | 2025 | |
| Apyx Medical Corporation | $34.90 | 2019-2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Argentum Medical | $34.37 | 2021 | |
| Ethicon US, LLC | $30.71 | 2020 | |
| Acelrx Pharmaceuticals, INC. | $12.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dana Coberly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.